BlackRock’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,971
Closed -$67.2K 5781
2025
Q4
$67.2K Buy
30,971
+366
+1% +$1.49K ﹤0.01% 4986
2025
Q3
$169K Buy
30,605
+1,368
+5% +$10.5K ﹤0.01% 4714
2025
Q2
$219K Buy
29,237
+7,262
+33% +$52.7K ﹤0.01% 4650
2025
Q1
$144K Buy
21,975
+490
+2% +$5.79K ﹤0.01% 4672
2024
Q4
$283K Hold
21,485
﹤0.01% 4554
2024
Q3
$122K Hold
21,485
﹤0.01% 4635
2024
Q2
$126K Sell
21,485
-119,466
-85% -$1.07M ﹤0.01% 4641
2024
Q1
$1.27M Sell
140,951
-3,295
-2% -$39.3K ﹤0.01% 4132
2023
Q4
$1.59M Buy
144,246
+11,611
+9% +$129K ﹤0.01% 4120
2023
Q3
$2.35M Buy
132,635
+4,513
+4% +$164K ﹤0.01% 3934
2023
Q2
$7.03M Buy
128,122
+30,405
+31% +$1.94M ﹤0.01% 3576
2023
Q1
$6.65M Sell
97,717
-2,271
-2% -$177K ﹤0.01% 3515
2022
Q4
$6.06M Buy
99,988
+3,535
+4% +$329K ﹤0.01% 3637
2022
Q3
$9.69M Buy
96,453
+4,277
+5% +$498K ﹤0.01% 3443
2022
Q2
$8.13M Buy
92,176
+65,890
+251% +$8.05M ﹤0.01% 3603
2022
Q1
$3.99M Sell
26,286
-957
-4% -$178K ﹤0.01% 4082
2021
Q4
$8.68M Buy
27,243
+27,173
+38,819% +$9.58M ﹤0.01% 3761
2021
Q3
$32K Sell
70
-12
-15% -$3.8K ﹤0.01% 5349
2021
Q2
$25K Buy
+82
New +$24.4K ﹤0.01% 5267

Other funds holding RBOT

BlackRock's RBOT Position: Q1 2026 in Review

BlackRock sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 30,971 shares — an estimated $67.2K sold.

BlackRock first reported a position in RBOT in Q2 2021 and held it in 19 quarters. The position peaked at $9.69M in Q3 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • BlackRock reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • BlackRock sold 30,971 Vicarious Surgical shares in Q1 2026, an estimated $67.2K.
  • BlackRock first reported a position in Vicarious Surgical in Q2 2021 and held it in 19 quarters.
  • BlackRock's Vicarious Surgical position peaked at $9.69M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.